货号:A401976
同义名:
谷甾醇
/ β-Sitosterol; 22,23-Dihydrostigmasterol
β-Sitosterol是一种植物甾醇,具有抗炎、抗氧化和抗肿瘤活性。它能够干扰细胞信号通路,影响细胞周期、增殖及凋亡。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | β-Sitosterol (beta-sitosterol, BS), a plant derived nutrient with anticancer properties against breast cancer, prostate cancer, colon cancer, lung cancer, stomach cancer, ovarian cancer, and leukemia[3]. β-sitosterol significantly ameliorated HFWD(high-fat western-style diet)-induced fatty liver and metabolic abnormalities, including elevated levels of hepatic total lipids, triacylglycerols, cholesterol and liver histopathology. It decreased the levels of intestinal bile acids, accompanied by markedly increased fecal lipid levels.β-Sitosterol was less effective in affecting most of these parameters[4]. β-sitosterol protected against in vitro H/R(hypoxia/reoxygenation)-induced cardiomyocyte injury and in vivo myocardial I/R (ischemia/reperfusion) injury[5]. The combination of β-sitosterol and naringenin exerted a synergistic effect on wound closure without decreasing the viability of fibroblasts, increased antioxidant defense mechanism and decreased IL-β[6]. |
| Concentration | Treated Time | Description | References | |
| Bone marrow-derived macrophages (BMDMs) | 5, 25, 50 µM | 1 day | To investigate the effect of BS on macrophage polarization. Results showed that BS significantly repressed M1 polarization and augmented M2 polarization. In 25 μM BS-treated M1-polarized BMDMs, the expression of iNOS, IL-1β, CD86, and MHCII was reduced by 50.2%, 47.1%, 87.1%, and 31.3%, respectively, while in 25 μM BS-treated M2-polarized BMDMs, the expression of arginase-1, IL-10, CD163, and CD206 was increased by 65.6%, 107.4%, 23.5%, and 51.3%, respectively. | Pharm Biol. 2019 Dec;57(1):161-168 |
| CHO-CCK1R-W166A cells | 100 µM | 15 minutes | To study the effect of β-sitosterol on CCK1R W166A mutant, results showed that 100 μM β-sitosterol had no effect on CCK signaling. | Clin Nutr. 2016 Dec;35(6):1374-1379 |
| CHO-CCK1R-Y237A cells | 100 µM | 15 minutes | To study the effect of β-sitosterol on CCK1R Y237A mutant, results showed that 100 μM β-sitosterol had no effect on CCK signaling. | Clin Nutr. 2016 Dec;35(6):1374-1379 |
| CHO-CCK1R-Y140A cells | 100 µM | 15 minutes | To study the effect of β-sitosterol on CCK1R Y140A mutant, results showed that 100 μM β-sitosterol had no effect on CCK signaling. | Clin Nutr. 2016 Dec;35(6):1374-1379 |
| CHO-CCK2R cells | 100 µM | 15 minutes | To study the effect of β-sitosterol on CCK2R function, results showed that 100 μM β-sitosterol had no significant impact on CCK2R function. | Clin Nutr. 2016 Dec;35(6):1374-1379 |
| SRD15-CCK1R cells | 100 µM | 15 minutes | To study the effect of β-sitosterol on CCK1R signaling in a high cholesterol environment, results showed that 100 μM and 10 μM β-sitosterol significantly improved the defective signaling of CCK1R. | Clin Nutr. 2016 Dec;35(6):1374-1379 |
| CHO-CCK1R cells | 100 µM | 15 minutes | To study the effect of β-sitosterol on CCK1R signaling in a high cholesterol environment, results showed that 100 μM and 10 μM β-sitosterol significantly improved the defective signaling of CCK1R. | Clin Nutr. 2016 Dec;35(6):1374-1379 |
| CuFi-1 cells | 100 nM | 16 hours | Β-Sitosterol significantly inhibited P. aeruginosa-induced expression of IL-8, GRO-α, and GRO-β | Front Pharmacol. 2017 May 12;8:236 |
| IB3-1 cells | 100 nM | 16 hours | Β-Sitosterol significantly inhibited P. aeruginosa-induced expression of IL-8, GRO-α, and GRO-β | Front Pharmacol. 2017 May 12;8:236 |
| HEK293 cells | 150–450 μg/mL | 24 hours | Inhibited TNF-α or IAV-induced NF-κB activation | Acta Pharmacol Sin. 2020 Sep;41(9):1178-1196 |
| A549 cells | 150–450 μg/mL | 24 hours | Suppressed inflammatory response in IAV-infected cells via NF-κB and p38 MAPK signaling, reducing pro-inflammatory cytokines and chemokines | Acta Pharmacol Sin. 2020 Sep;41(9):1178-1196 |
| Bovine mammary epithelial cells (MAC-T) | 1 µM | 24 hours | Β-Sitosterol significantly reduced LPS-induced oxidative stress and inflammation, while increasing the expression of anti-apoptotic proteins and activating the HIF-1α/mTOR signaling pathway to inhibit apoptosis and improve lipid synthesis-related gene expression | Int J Mol Sci. 2023 Sep 27;24(19):14644 |
| 293 T cells | 5 μg/mL, 10 μg/mL, 20 μg/mL | 24, 48, 72 hours | No significant effect on cell viability | Hum Cell. 2024 Jul;37(4):1156-1169. |
| HCCLM3 cells | 5 μg/mL, 10 μg/mL, 20 μg/mL | 24, 48, 72 hours | Inhibited cell viability and proliferation | Hum Cell. 2024 Jul;37(4):1156-1169. |
| Huh-7 cells | 5 μg/mL, 10 μg/mL, 20 μg/mL | 24, 48, 72 hours | Inhibited cell viability and proliferation | Hum Cell. 2024 Jul;37(4):1156-1169. |
| U87 cells | 0, 10, 20, 30, 40, 50 µM | 24, 48, 72 hours | Β-Sitosterol significantly inhibited the proliferation and viability of U87 cells, with IC50 values of 35.82 μM at 24 h, 31.75 μM at 48 h, and 9.43 μM at 72 h. | Acta Biochim Biophys Sin (Shanghai). 2024 Feb 25;56(2):223-238 |
| MDCK cells | 0.975 µg/mL | 3 days | Evaluate the in vitro antiviral activity of β-Sitosterol against A/H1N1 virus, showing significant antiviral effects | Vaccines (Basel). 2023 Jan 19;11(2):228 |
| Vascular Smooth Muscle Cells (VSMCs) | 5, 10, 20 µM | 30 minutes | Inhibited oxLDL-induced lipid deposition and phenotypic transformation in VSMCs | Heliyon. 2024 Aug 2;10(15):e35639 |
| C2C12 myotubes | 0.5 mM | 48 hours | To evaluate the protective effect of β-sitosterol on dexamethasone-induced muscle atrophy. Results showed that β-sitosterol increased myotube width, restored the fusion index, and reduced the expression of MAFbx and MuRF1. | Nutrients. 2022 Jul 14;14(14):2894 |
| Huh7 cells | 8.71±0.21 µg/mL (IC50) | 48 hours | Β-Sitosterol significantly reduced Huh7 cell viability and induced apoptosis via caspase pathway activation | Molecules. 2020 Jul 2;25(13):3021 |
| HepG2 cells | 6.85±0.61 µg/mL (IC50) | 48 hours | Β-Sitosterol inhibited HepG2 cell proliferation in a dose-dependent manner, induced apoptosis and activated caspase-3 and -9 | Molecules. 2020 Jul 2;25(13):3021 |
| Administration | Dosage | Frequency | Description | References | ||
| ICR mice | Depression model (TST and FST) | Intraperitoneal injection | 0.1–100 mg/kg | Single administration, tested after 60 minutes | To evaluate the antidepressant effects of β-sitosterol and its derivatives. Results showed that Sit-S (4 mg/kg) exhibited the strongest antidepressant-like activity in the TST, mediated by the 5-HT, DA, and GABAergic systems. | RSC Adv. 2018 Jan 2;8(2):671-680 |
| Mice | High-fat western-style diet-induced NAFLD model | Dietary intake | 0.4% diet | 17 weeks | To investigate the effects of β-sitosterol on alleviating HFWD-induced NAFLD. Results showed that β-sitosterol significantly ameliorated HFWD-induced fatty liver and metabolic abnormalities, including decreased levels of hepatic total lipids, triacylglycerols, cholesterol and improved liver histopathology. | Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Oct;1863(10):1274-1284 |
| C57BL/6J male mice | DSS-induced colitis model | Dietary addition | 0.4% dietary addition | After 1 week of feeding, treated with 1.5% DSS in drinking water for 5 days | Β-Sitosterol significantly inhibited colon shortening, lowered fecal hemoglobin contents, and reduced the severity of colitis in the middle and distal colon. | Food Funct. 2017 Nov 15;8(11):4179-4186 |
| Adult male Wistar rats | Nitroglycerin-induced migraine model | Intraperitoneal injection | 10 mg/kg | Daily for 10 days | Β-Sitosterol significantly improved anxiety behaviors in migraine-induced rats by alleviating oxidative/nitrosative stress and enhancing mitochondrial function. | CNS Neurosci Ther. 2024 Sep;30(9):e14892 |
| Mice | Anxiety model | Intraperitoneal injection and oral gavage | 100 mg/kg | 1 hour before testing | Β-Sitosterol shows anxiolytic effects when administered alone and in combination with the SSRI fluoxetine | Cell Rep Med. 2021 May 18;2(5):100281 |
| Wistar rats | Trypanosoma congolense infection model | Oral | 15 and 30 mg/kg | Daily administration for 14 days | Β-Sitosterol significantly reduced parasitemia, ameliorated parasite-induced anemia, and significantly down-regulated the expression of TconTS1 gene. | Front Microbiol. 2023 Sep 27;14:1282257 |
| C57BL/6 mice | 70% hepatectomy model | Dietary supplementation | 20 mg/kg/day | Once daily until 72 hours post-surgery | To verify the promoting effect of β-sitosterol diet on liver regeneration, results showed that β-sitosterol significantly enhanced liver regeneration rate and accelerated TRAS resolution. | Int J Nanomedicine. 2024 Aug 8;19:8117-8137 |
| C57BL/6 mice | Collagen-induced arthritis (CIA) model | Intraperitoneal injection | 20 or 50 mg/kg | Every 2 days until the end of the experiment | To evaluate the therapeutic effect of BS on CIA. Results showed that BS treatment significantly alleviated ankle swelling (vehicle group: 3.13 ± 0.102 mm; 20 mg/kg BS group: 2.64 ± 0.043 mm; 50 mg/kg BS group: 2.36 ± 0.084 mm), reduced the levels of collagen-specific antibodies (IgG and IgG1, but not IgG2c, p<0.05) and pro-inflammatory cytokines (p<0.05), and increased the level of anti-inflammatory cytokine IL-10. | Pharm Biol. 2019 Dec;57(1):161-168 |
| C57BL/6 mice | Dexamethasone-induced muscle atrophy model | Oral | 200 mg/kg | Once daily for 3 weeks | To evaluate the protective effect of β-sitosterol on dexamethasone-induced muscle atrophy. Results showed that β-sitosterol protected mice from muscle mass loss, increased the thickness of gastrocnemius muscle fibers, restored grip strength and creatine kinase activity, and reduced the expression of MAFbx and MuRF1. | Nutrients. 2022 Jul 14;14(14):2894 |
| ApoE−/− mice | High-fat diet-induced atherosclerosis model | Oral | 25, 50, 100 mg/kg | Once daily for 1 month | Β-Sitosterol alleviates atherosclerosis by regulating CAT and inhibiting the PI3K/Akt/mTOR signaling pathway | Heliyon. 2024 Aug 2;10(15):e35639 |
| Red swamp crayfish (Procambarus clarkii) | White spot syndrome virus (WSSV) infection model | Intraperitoneal injection | 50 mg/kg | Single injection, observed up to 72 hours | Β-Sitosterol significantly inhibited WSSV replication, reduced viral gene transcription levels, and increased the survival rate of infected crayfish (57.14%). | Int J Mol Sci. 2022 Sep 9;23(18):10448 |
| BALB/c mice | Influenza A virus-induced acute lung injury model | Intragastric | 50, 200 mg/kg/day | Once daily for 2 days | Ameliorated IAV-mediated recruitment of pathogenic cytotoxic T cells and immune dysregulation, protected mice from lethal IAV infection | Acta Pharmacol Sin. 2020 Sep;41(9):1178-1196 |
| Zebrafish (Danio rerio) | CuSO4-induced inflammation model | Immersion | 70 or 100 μg/mL | Pretreatment for 1 h followed by exposure to CuSO4 for 20 min or 1 h | Β-Sitosterol significantly reduced CuSO4-induced oxidative stress, upregulated the expressions of sod and gpx4b, and inhibited neutrophil migration and the expressions of inflammatory genes il-8 and myd88. | Antioxidants (Basel). 2023 Feb 6;12(2):391 |
| C57BL/6 mice | U87 xenograft nude mouse model | Intraperitoneal injection | 80 mg/kg | Once daily for 28 days | Β-Sitosterol significantly inhibited tumor growth, reducing the average tumor size from 1282.164±221.869 mm3 in the control group to 113.126±81.405 mm3 in the β-sitosterol group, and the mean tumor weight from 0.899±0.180 g to 0.054±0.033 g. | Acta Biochim Biophys Sin (Shanghai). 2024 Feb 25;56(2):223-238 |
| C57BL/6 mice | S. pneumoniae infection model | Subcutaneous injection | 80 mg/kg | Treatment started 1 hour after infection, every 4 hours for 48 hours | To evaluate the protective effect of β-sitosterol against S. pneumoniae infection, results showed that β-sitosterol significantly reduced mortality and alleviated pulmonary inflammation in mice. | Sci Rep. 2015 Dec 3;5:17668 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.41mL 0.48mL 0.24mL |
12.06mL 2.41mL 1.21mL |
24.11mL 4.82mL 2.41mL |
|
| CAS号 | 83-46-5 |
| 分子式 | C29H50O |
| 分子量 | 414.71 |
| SMILES Code | CC[C@@H](C(C)C)CC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C |
| MDL No. | MFCD00003631 |
| 别名 | 谷甾醇 ;β-Sitosterol; 22,23-Dihydrostigmasterol; (-)-beta-Sitosterol, 22,23-Dihydrostigmasterol, 24-alpha-Ethylcholesterol, AI3-26020, alpha-Dihydrofucosterol, Angelicin, Azuprostat, beta-Sitosterol, CCRIS 5529, Cinchol, Cupreol, Harzol, Nimbosterol, Prostasal, Quebrachol, Rhamnol, Triastonal; SKF 14463; Rhamnol; NSC 8096; NSC 49083; NSC 18173; Cupreol; Betaprost; Azuprostat; 24α-ethyl Cholesterol |
| 运输 | 蓝冰 |
| InChI Key | KZJWDPNRJALLNS-VJSFXXLFSA-N |
| Pubchem ID | 222284 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
无水乙醇: 3.5 mg/mL(8.44 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1